Clinical and pathologic study of canine lymphoma: clinical staging, cell classification, and therapy.
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000150:complications; D003520:Cyclophosphamide / Q000627:therapeutic use; D004195:Disease Models, Animal; D004283:Dog Diseases / Q000188:drug therapy / Q000473:pathology; D004285:Dogs; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D005260:Female; D008223:Lymphoma / Q000150:complications / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000628:therapy / Q000662:veterinary*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D011446:Prospective Studies; D012075:Remission, Spontaneous; D013156:Splenectomy; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone